MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kondo, Y.
Right arrow Articles by Lazo, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kondo, Y.
Right arrow Articles by Lazo, J. S.

0026-895X/97/020195-07$3.00/0
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY 52:195-201 (1997).

Enhanced Apoptosis in Metallothionein Null Cells

Yukihiro Kondo,1 James M. Rusnak, Dale G. Hoyt, Catherine E. Settineri, Bruce R. Pitt, and John S. Lazo

Department of Pharmacology, University of Pittsburgh and Experimental Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15261

Metallothioneins (MTs) are major intracellular, zinc-binding proteins with antioxidant properties. Mouse embryonic cells null for MT due to loss of functional MT I and II genes (MT-/-) were more susceptible to apoptotic death after exposure to tert-butyl hydroperoxide or the anti-cancer agents cytosine arabinoside, bleomycin, melphalan, and cis-dichlorodiammineplatinum(II) compared with wild-type mouse embryonic cells (MT+/+). We measured basal levels of the tumor suppressor protein p53 and the death effector protein Bax and found the basal levels of both proteins were higher in MT null cells compared with MT+/+ cells. After treatment with the DNA-damaging agent cis-dichlorodiammineplatinum(II), p53 protein levels were induced in both MT+/+ and MT-/- cells with MT null cells always maintaining the highest p53 levels. The elevated sensitivity to apoptosis was not restricted to embryonic cells. Primary pulmonary fibroblasts were isolated from distinct litters of MT null, heterozygous, and wild-type mice, and all had undetectable basal MT levels. Zinc exposure increased MT levels in the wild-type and heterozygous fibroblasts but not in the MT null fibroblasts. Consistent with the induced MT levels, we found MT+/+ and MT+/- embryonic cells were less sensitive to cis-dichlorodiammineplatinum(II)-induced apoptosis compared with MT-/- cells. Our results implicate MT as a stress-responsive factor that can regulate apoptotic engagement.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. L. Fattman, F. Gambelli, G. Hoyle, B. R. Pitt, and L. A. Ortiz
Epithelial expression of TIMP-1 does not alter sensitivity to bleomycin-induced lung injury in C57BL/6 mice
Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L572 - L581.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
M Filipic, T Fatur, and M Vudrag
Molecular mechanisms of cadmium induced mutagenicity
Human and Experimental Toxicology, February 1, 2006; 25(2): 67 - 77.
[Abstract] [PDF]


Home page
Exp. Biol. Med.Home page
P. Schott-Ohly, A. Lgssiar, H.-J. Partke, M. Hassan, N. Friesen, and H. Gleichmann
Prevention of Spontaneous and Experimentally Induced Diabetes in Mice With Zinc Sulfate-Enriched Drinking Water Is Associated with Activation and Reduction of NF-{kappa}B and AP-1 in Islets, Respectively
Experimental Biology and Medicine, December 1, 2004; 229(11): 1177 - 1185.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. Somji, S. H. Garrett, M. A. Sens, V. Gurel, and D. A. Sens
Expression of Metallothionein Isoform 3 (MT-3) Determines the Choice between Apoptotic or Necrotic Cell Death in Cd+2-Exposed Human Proximal Tubule Cells
Toxicol. Sci., August 1, 2004; 80(2): 358 - 366.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. D. Kobayashi, J. M. Voyich, K. R. Braughton, A. R. Whitney, W. M. Nauseef, H. L. Malech, and F. R. DeLeo
Gene Expression Profiling Provides Insight into the Pathophysiology of Chronic Granulomatous Disease
J. Immunol., January 1, 2004; 172(1): 636 - 643.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
R. Shimoda, W. E. Achanzar, W. Qu, T. Nagamine, H. Takagi, M. Mori, and M. P. Waalkes
Metallothionein Is a Potential Negative Regulator of Apoptosis
Toxicol. Sci., June 1, 2003; 73(2): 294 - 300.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
E. E. Brako, A. K. Wilson, M. M. Jonah, C. A. Blum, E. A. Cerny, K. L. Williams, and M. H. Bhattacharyya
Cadmium Pathways during Gestation and Lactation in Control versus Metallothoinein 1,2-Knockout Mice
Toxicol. Sci., February 1, 2003; 71(2): 154 - 163.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
P. J. Smith, M. Wiltshire, S. Davies, S.-F. Chin, A. K. Campbell, and R. J. Errington
DNA damage-induced [Zn2+]i transients: correlation with cell cycle arrest and apoptosis in lymphoma cells
Am J Physiol Cell Physiol, August 1, 2002; 283(2): C609 - C622.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. M. L. Janssen, W. van Duijn, F. J. G. M. Kubben, G. Griffioen, C. B. H. W. Lamers, J. H. J. M. van Krieken, C. J. H. van de Velde, and H. W. Verspaget
Prognostic Significance of Metallothionein in Human Gastrointestinal Cancer
Clin. Cancer Res., June 1, 2002; 8(6): 1889 - 1896.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Ghoshal, S. Majumder, Q. Zhu, J. Hunzeker, J. Datta, M. Shah, J. F. Sheridan, and S. T. Jacob
Influenza Virus Infection Induces Metallothionein Gene Expression in the Mouse Liver and Lung by Overlapping but Distinct Molecular Mechanisms
Mol. Cell. Biol., December 15, 2001; 21(24): 8301 - 8317.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G.-W. Wang, Z. Zhou, J. B. Klein, and Y. J. Kang
Inhibition of hypoxia/reoxygenation-induced apoptosis in metallothionein-overexpressing cardiomyocytes
Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2292 - H2299.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
Y. Liu, J. Liu, S. M. Habeebu, M. P. Waalkes, and C. D. Klaassen
Metallothionein-I/II Null Mice Are Sensitive to Chronic Oral Cadmium-Induced Nephrotoxicity
Toxicol. Sci., September 1, 2000; 57(1): 167 - 176.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. S. Habeebu, J. Liu, Y. Liu, and C. D. Klaassen
Metallothionein-Null Mice Are More Sensitive than Wild-Type Mice to Liver Injury Induced by Repeated Exposure to Cadmium
Toxicol. Sci., May 1, 2000; 55(1): 223 - 232.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. L. Pearce, R. E. Gandley, W. Han, K. Wasserloos, M. Stitt, A. J. Kanai, M. K. McLaughlin, B. R. Pitt, and E. S. Levitan
Role of metallothionein in nitric oxide signaling as revealed by a green fluorescent fusion protein
PNAS, January 4, 2000; 97(1): 477 - 482.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Levadoux, C. Mahon, J. H. Beattie, H. M. Wallace, and J. E. Hesketh
Nuclear Import of Metallothionein Requires Its mRNA to Be Associated with the Perinuclear Cytoskeleton
J. Biol. Chem., December 3, 1999; 274(49): 34961 - 34966.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. Sun
Alterations of SAG mRNA in human cancer cell lines: requirement for the RING finger domain for apoptosis protection
Carcinogenesis, October 1, 1999; 20(10): 1899 - 1903.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W.-Y. Zhu and P. W. Melera
Metallothionein Is Overexpressed by Hamster Fibroblasts Selected for Growth in 15 pM Folinic Acid and Provides a Growth Advantage in Low Folate
Cancer Res., September 1, 1999; 59(17): 4194 - 4199.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Duan, Y. Wang, M. Aviram, M. Swaroop, J. A. Loo, J. Bian, Y. Tian, T. Mueller, C. L. Bisgaier, and Y. Sun
SAG, a Novel Zinc RING Finger Protein That Protects Cells from Apoptosis Induced by Redox Agents
Mol. Cell. Biol., April 1, 1999; 19(4): 3145 - 3155.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Penkowa, J. Carrasco, M. Giralt, T. Moos, and J. Hidalgo
CNS Wound Healing Is Severely Depressed in Metallothionein I- and II-Deficient Mice
J. Neurosci., April 1, 1999; 19(7): 2535 - 2545.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. J. Murphy, G. K. Andrews, D. Bittel, D. J. Discher, J. McCue, C. J. Green, M. Yanovsky, A. Giaccia, R. M. Sutherland, K. R. Laderoute, et al.
Activation of Metallothionein Gene Expression by Hypoxia Involves Metal Response Elements and Metal Transcription Factor-1
Cancer Res., March 1, 1999; 59(6): 1315 - 1322.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
G. D. Ceneviva, E. Tzeng, D. G. Hoyt, E. Yee, A. Gallagher, J. F. Engelhardt, Y.-M. Kim, T. R. Billiar, S. A. Watkins, and B. R. Pitt
Nitric oxide inhibits lipopolysaccharide-induced apoptosis in pulmonary artery endothelial cells
Am J Physiol Lung Cell Mol Physiol, October 1, 1998; 275(4): L717 - L728.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics